Results 121 to 130 of about 1,055,250 (236)

Cutaneous‐only hypersensitivity reaction presumed due to intravenous administration of atracurium in a dog

open access: yesVeterinary Record Case Reports, Volume 14, Issue 4, November 2026.
Summary There are limited case reports of hypersensitivity reactions to neuromuscular blocking agents (NMBAs) in veterinary species, and none describe cutaneous‐only signs. This case report describes a Grade 1 cutaneous‐only hypersensitivity reaction to atracurium in a 7‐year‐old dog undergoing general anaesthesia for cataract surgery with bilateral ...
Kar Yee Phoon, Rob Ward
wiley   +1 more source

The effect of medication reviews on reducing medication anticholinergic burden in elderly patients [PDF]

open access: yes, 2017
Anticholinergic side effects of medications often misdiagnosed as cognitive function decline in the elderly. The study aims to explore the effectiveness of home medication reviews on reducing anticholinergic burden caused by medications with ...
Morrissey, Hana   +2 more
core   +1 more source

Temporal Trends Over Two Decades in the Use of Anticholinergic Drugs Among Older Community-Dwelling People in Helsinki, Finland. [PDF]

open access: yesDrugs Aging, 2022
Rinkinen MO   +7 more
europepmc   +1 more source

Reports of side effects associated with the use of drugs 1982 [PDF]

open access: yes, 1982
The National Drugs Advisory Board received 540 reports during 1982 from which 1051 side-effects were reported. 39% of the reactions received occurred in association with drugs affecting the central nervous system, over half concerned analgesics, 18% of
National Drugs Advisory Board (NDAB)
core  

Pain Management in Older Adults: An Interprofessional Training Approach Assessed by Script Concordance Tests

open access: yesPain Practice, Volume 26, Issue 8, November 2026.
ABSTRACT Background Optimal perioperative pain management in older adults challenges anesthesiologists due to increased drug sensitivity, altered pharmacokinetics, and limitations of pain assessment tools in cognitively impaired patients. This study evaluated whether a single 60‐min structured collaborative training session between a geriatrician and a
Alexandre Meurant   +4 more
wiley   +1 more source

Anticholinergic burden and incident dementia: a Swedish nationwide case-control study

open access: yesAlzheimer’s Research & Therapy
Background Cumulative exposure to multiple drugs with anticholinergic properties, known as anticholinergic burden, has been linked to dementia risk. We aimed to thoroughly assess this relationship by examining not only anticholinergic potency, cumulative
Nanbo Zhu   +6 more
doaj   +1 more source

Gabapentinoids‐duloxetine combination therapy for chronic pain: A mechanism oriented rational to bridge theoretical knowledge and real life setting

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 10, Page 3333-3353, October 2026.
Chronic pain represents a complex debilitating condition that extends beyond the protective function of physiological pain, often persisting as an independent disease entity. Chronic primary and secondary pain syndromes reflect a multifaceted continuum involving nociceptive, neuropathic and nociplastic mechanisms.
Stefania Nobili   +6 more
wiley   +1 more source

Antipsychotic Drug Interactions and Short‐Term Mortality Risk in People With Dementia: A National Cohort Study

open access: yesClinical Pharmacology &Therapeutics, Volume 120, Issue 4, Page 1081-1091, October 2026.
Antipsychotics are often prescribed in the management of behaviors and psychological symptoms of dementia. While the potential harms of antipsychotic use in people with dementia have been established, little is known about the risk associated with antipsychotic drug–drug interactions (DDIs). This study aims to examine the patterns of antipsychotic DDIs
Edward C.Y. Lau   +7 more
wiley   +1 more source

National Drugs Advisory Board annual report, 1990.

open access: yes, 1990
The National Drugs Advisory Board was established by the Minister for Health in 1966 by the National Drugs Advisory Board (Establishment) Order 1966 (5.1. No.163 of 1966) under the Health (Corporate Bodies) Act 1961.
National Drugs Advisory Board (NDAB)
core  

Home - About - Disclaimer - Privacy